Tasigna 150mg Capsule: Treatment for Chronic Myeloid Leukemia

Tasigna 150mg Capsule

Uses:

• Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML) in adults and pediatrics, including newly diagnosed patients and those who have experienced side effects from previous treatments, such as Imatinib.

Therapeutic Effects:

• Tasigna 150mg disrupts the signaling route of the BCR-ABL tyrosine kinase protein, inhibiting the growth and spread of cancer cells.

Important Safety Information:

• Allergies: Do not take if allergic to Nilotinib or other ingredients.
• Medical History: Inform your doctor if you have heart conditions, chest pain, brain stroke, claudication, liver or pancreas disorders, or potassium/magnesium deficiencies.
• Medications: Inform your doctor about all medications, especially cholesterol-lowering drugs.
• Pregnancy and Breastfeeding: Tasigna 150mg is unsafe during pregnancy and breastfeeding unless necessary.
• Driving: Do not drive or operate machinery due to potential side effects like nausea and vision changes.
• Alcohol: Avoid alcohol while taking Tasigna 150mg.
• Storage: Keep out of reach of children, store below 30°C, and in original packaging to protect from light and moisture.

Interaction with Other Drugs:

• Inform your healthcare professional about all medications, including prescription, over-the-counter, nutritional supplements, and herbal products. Certain medications may reduce effectiveness or cause undesirable side effects.

Side Effects:

• Serious: Sudden weight gain, swelling in hands, feet, ankles, or face, chest pain, blood pressure changes, discoloration of tongue, lips, or skin (blue), abnormal heart rhythm, hair loss, vision problems, stomach pain, vomiting of blood, blood in stools, yellowing of the skin, eyes, and dark urine, high blood sugar levels, sensitivity to light.
• Common: Nausea, vomiting, diarrhea, headache, muscle pain, stomach pain, tiredness, constipation, slow growth in children, pneumonia, loss of appetite, sleeplessness, depression, anxiety, bloating, and flatulence.

Monitoring:

• Regular blood tests to monitor liver and pancreas function, blood cell counts, heart condition, electrolytes, sugar, and fats.

FAQ:

• Q1: Can Tasigna 150mg cause liver damage?

  • Tasigna 150mg may cause liver function abnormalities, which may indicate liver damage. Regular blood tests are necessary to monitor liver function.

• Q2: How does Tasigna 150mg differ from other medications used to treat chronic myeloid leukemia, such as Imatinib?

  • Tasigna 150mg is more selective for the BCR-ABL protein and more potent in inhibiting its activity. It is effective in patients who have developed resistance to Imatinib.

• Q3: What are the potential long-term effects of Tasigna 150mg on the body?

  • Potential long-term effects include cardiovascular events, liver dysfunction, pancreatic enzyme elevation, and fluid retention. These side effects are generally rare.

• Q4: How to monitor the effects of Tasigna 150mg over the course of treatment?

  • Monitor through regular blood tests, electrocardiograms, and imaging studies.

• Q5: Who should not take Tasigna 150mg?

  • Tasigna 150mg should not be taken by pregnant or breastfeeding women, or by people with severe liver or kidney disease, a history of pancreatitis, or a prolonged QT interval.

Fact Box:

• Molecule name: Nilotinib
• Therapeutic class: Antineoplastic drug
• Pharmacological class: Tyrosine Kinase inhibitors
• Indications: Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Теги: drug, tasigna, medicine, capsule, 150mg